| Gene symbol | ERBB2 | Synonyms | CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | erb-b2 receptor tyrosine kinase 2 | ||||
| GTO ID | GTC3350 |
| Trial ID | NCT05745454 |
| Disease | Solid Tumor |
| Altered gene | HER2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HER2-E-CAR-T cells |
| Generation | 2nd |
| Recruitment status | Not Recruiting |
| Title | A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | su haichuan |
| Other ID(s) | HER2-E-CART |
| Cohort 1 | |||||||
|
|||||||